Search - tctmd.com

Displaying 1 - 20 of 61

Sort: Relevancy | Date

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

Todd Neale

October 02, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

L.A. McKeown

November 26, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

L.A. McKeown

March 27, 2024

News Daily News

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

L.A. McKeown

August 31, 2023

News Daily News

LDL Control Remains Poor in CAD Patients: NHANES

Michael O'Riordan

July 05, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Conference News AHA 2021

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Shelley Wood

November 15, 2021

News Daily News

Could an App Replace Statin Prescribing by Doctors?

Michael O'Riordan

September 08, 2021

News Daily News

FDA Approves Vericiguat for High-risk Patients With HF

Michael O'Riordan

January 20, 2021

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

Advertisement

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Need a Statin for Primary Prevention? There’s an App for That

Biologic Winrevair Wins FDA Approval for Treatment of PAH

First Drugs Chosen for Medicare Negotiations Hit Close to Home for Cardiologists

LDL Control Remains Poor in CAD Patients: NHANES

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops

Could an App Replace Statin Prescribing by Doctors?

FDA Approves Vericiguat for High-risk Patients With HF

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Signal of Aortic Stenosis Risk With Celecoxib

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content